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Interventional trials
The investigator actively intervenes to change one variable, then examines dependent variables (outcomes). Interventional trials were further divided Uncontrolled clinical trial-Trials where there is no concurrent comparison group. Non-random controlled trial-Concurrent comparison group allocated by means of some nonrandom process (e.g. convenience or clinical judgment).
ly allocated into treatment and control groups.
All prospective comparative clinical interventional trials (hence interventional trials involving animals and human volunteers, evaluation of equipment, comparative trials using case, cohort or historical controls, and retrospective and observational studies were excluded) were then evaluated according to
Number of authors.
Ethics approval-Statements confirming institutional ethics committee approval. Informed consent-Statements confirming informed consent from patient/guardian or waived by ethics approval. Competing financial interest-Any declaration of funding from a source with competing financial interests. Eligibility criteria-Inclusion and exclusion criteria provided for patients in the trial. before the trial commenced was provided. mechanism used to generate random assignment. hospital registration numbers etc. was considered unacceptable. Patients accounted for-A statement to mention any drop out of enrolled patients and why they were excluded from the study. Blind assessment of outcome-A statement that the observer of outcomes was unaware of treatment assignment. Adverse outcomes-Details or presence or absence of side-effects or complications, not related to the primary outcome variable. Statistical method stated-Appropriate statistical tests listed. Type I error-This was defined as more than 10
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comparisons among the treatment groups without correction or consideration of multiple tests (e.g. ANOVA, Bonferroni correction). No published consensus exists for the maximum number of between-group comparisons after which compensation for a type I error is appropriate. Type II error-For trials with no statistically significant differences between groups in which analysis was performed. Department-The country of origin of the articles was taken as that of the first author. We were particularly interested in comparing Australia and New Zealand versus the rest of the world. trial). Those trials were then omitted from the analysis of that criterion.
Comparisons of the above criteria were then made between Group 1 and Group 2 using chi-square test or Fischer's exact test where applicable. year period, without reference per se to the number of articles. We acknowledge the fact that we made multiple the potential of making a type I or type II error.
RESULTS
interpreted with caution.
In an attempt to determine if editorial policy could have explained some of the results in this article, we of interest, ethics approval and the need for animal studies to comply with National Health and Medical Research Council guidelines, we were not aware of any other overt and published or covert editorial policy that could explain any differences which may have applied.
The decrease in percentage of animal/laboratory (P=0.05), suggests there was more of an emphasis in focusing on human trials which is much more likely to be applicable to the everyday practice of the clinical anaesthetist.
The percentage of review articles decreased whilst P the increase in the number of trials submitted for increase in the percentage of interventional trials, there was a nearly four-fold increase in the percentage P<0.0001), the highest level of evidence available for evaluating new therapies.
The number of articles with more than four P=0.001). This has also been documented in other studies. Reasons cited include increased complexity in statistical methods necessitating greater collaboration with epidemiologists and statisticians; increased specialitraditional practice of associating career advancement with increasing numbers of publications 5 .
Ethics approval and informed consent has increased P<0.0001). This Anaesthesia and Intensive Care, of the requirements outlined by the World 6 . This declaration requires that ethics committee (Institutional Review Board) approval and informed consent should be obtained. Furthermore, Anaesthesia and Intensive Care methods for allocating patients to treatments because the investigator could be un-blinded to the treatment assignment more likely to lead to exaggerated treatment effects, resulting in more trials with positive outcomes than . A blinded observer is another method to reduce bias in clinical trials. Though there was a statistically (P quality clinical trials. For trials where blinding is not feasible, the observers could be blinded to the study hypotheses. We considered that vigorous methods of blinding were necessary to convince readers that unblinding was unlikely (even if the authors stated that un-blinding did not occur).
Type II statistical error did improve but was not P=0.223 if the sample population matched the patients that they see in their own clinical practice.
CONCLUSION
The articles published in Anaesthesia and Intensive Care years in terms of study design. Overall, the quality of anaesthetic research has improved in Anaesthesia and Intensive Care over the past 25 years. However, there is still room for improvement.
